|
WO2018087715A1
|
|
An assay for determining hepatitis b clearance
|
|
WO2009052559A1
|
|
A diagnostic assay
|
|
WO2009026638A1
|
|
Marine-animal derived therapeutic and diagnostic agents for hepatitis b
|
|
EP2083848A1
|
|
Method of treatment and prophylaxis
|
|
WO2007140522A1
|
|
Detection and use of antiviral resistance mutations
|
|
WO2007045045A1
|
|
Antiviral resistance mutants and applications thereof
|
|
CN101248173A
|
|
Variants of hepatitis b virus with resistance to anti-viral nucleoside agents and applications thereof
|
|
SG161255A1
|
|
Variants of hepatitis b virus with resistance to anti-viral nucleoside agents and applications thereof
|
|
WO2006039739A1
|
|
Hepatitis b viral (hbv) mutants detection and application
|
|
EP1799814A1
|
|
Variants of hepatitis b virus with resistance to anti-viral nucleoside agents and applications thereof
|
|
WO2005111199A1
|
|
Therapeutic, prophylactic and diagnostic agents for hepatitis b
|
|
AU2005243607A1
|
|
Therapeutic, prophylactic and diagnostic agents for hepatitis B
|
|
US2005272031A1
|
|
Viral variants and uses therefor
|
|
US2007243213A1
|
|
HBV variants detection and application
|
|
USRE40233E
|
|
Viral variants and methods for detecting same
|
|
CA2529309A1
|
|
Viral polymerase and modulation thereof
|
|
AU2004247277A1
|
|
Viral polymerase and modulation thereof
|
|
AU2003250580A1
|
|
Mammalian grainyhead transcription factors
|
|
US2006162001A1
|
|
Mammalian grainyhead transcription factors
|
|
AU2003903275A0
|
|
Methods for detecting sequence variation
|
